Lactic acidosis is a critical medical condition characterized by the accumulation of lactate in the bloodstream, leading to a state of high anion gap metabolic acidosis (HAGMA). It is not a standalone disease but rather a manifestation of a severe underlying pathology that disrupts the delicate balance between lactate production and clearance. Understanding its causes, recognizing its clinical presentation, and initiating prompt, targeted treatment are paramount to improving patient outcomes.
Understanding the Precipitating Factors
The fundamental cause of lactic acidosis is a cellular shift from aerobic metabolism (which efficiently produces large amounts of ATP with water and carbon dioxide as byproducts) to anaerobic metabolism. In the anaerobic state, pyruvate—the end product of glycolysis—is converted into lactate to regenerate the NAD+ needed to sustain energy production, albeit inefficiently. This lactate then enters the bloodstream. The condition is broadly classified into two categories based on the presence or absence of overt tissue hypoxia.
Type A: Lactic Acidosis with Inadequate Oxygen Delivery
This is the most common form and results from systemic or regional hypoperfusion, leading to cellular hypoxia. The body’s demand for oxygen outstrips the supply.
- Systemic Shock: This is the leading cause. Any state of circulatory failure can precipitate Type A lactic acidosis.
- Septic Shock: Widespread infection leads to vasodilation, capillary leak, and impaired cellular oxygen utilization, causing profound tissue hypoperfusion.
- Cardiogenic Shock: Heart failure (e.g., from a massive myocardial infarction) prevents the heart from pumping enough oxygenated blood to meet the body’s needs.
- Hypovolemic Shock: Significant loss of blood or fluids (e.g., from trauma or severe dehydration) reduces circulating volume and, consequently, oxygen delivery.
- Obstructive Shock: A physical obstruction to blood flow, such as a large pulmonary embolism, impedes circulation.
- Regional Ischemia: A localized lack of blood flow can cause significant lactate production from the affected tissue. Examples include mesenteric ischemia (blocked blood flow to the intestines), acute limb ischemia, or compartment syndrome.
- Severe Hypoxemia: Conditions that drastically lower the oxygen content of the blood, such as severe respiratory failure, carbon monoxide poisoning (which prevents hemoglobin from releasing oxygen to tissues), or cyanide poisoning (which blocks cellular oxygen use), directly trigger anaerobic metabolism.
Type B: Lactic Acidosis without Inadequate Oxygen Delivery
In this category, there is no evidence of systemic or regional hypoxia. The acidosis is caused by other factors that either increase lactate production or impair its clearance.
- Type B1: Associated with Underlying Disease:
- Liver Failure: The liver is the primary organ responsible for clearing lactate from the blood (via the Cori cycle). In severe liver disease or cirrhosis, this clearance mechanism is compromised, allowing lactate to accumulate even at normal production rates.
- Malignancy: Certain cancers, particularly hematologic malignancies like leukemia and lymphoma, can produce large amounts of lactate due to their high metabolic rate and reliance on aerobic glycolysis (the “Warburg effect”).
- Thiamine (Vitamin B1) Deficiency: Thiamine is a crucial cofactor for the enzyme pyruvate dehydrogenase, which converts pyruvate into acetyl-CoA for entry into the Krebs cycle. Without thiamine, pyruvate is shunted towards lactate production. This is often seen in patients with alcoholism or severe malnutrition.
- Type B2: Caused by Drugs or Toxins:
- Metformin: This is a classic cause. While rare, metformin-associated lactic acidosis (MALA) is a severe complication, typically occurring in patients with renal impairment, which prevents the drug’s excretion. Metformin inhibits mitochondrial respiration, promoting anaerobic metabolism.
- Propofol: Prolonged, high-dose infusions can lead to Propofol Infusion Syndrome (PRIS), a rare but fatal condition characterized by lactic acidosis, rhabdomyolysis, and cardiovascular collapse.
- Toxins: Ethylene glycol and methanol poisoning can cause lactic acidosis as a component of their overall metabolic derangement.
- Other Medications: Nucleoside reverse-transcriptase inhibitors (NRTIs) used in HIV treatment, salicylates, and linezolid have also been implicated.
- Type B3: Stemming from Inborn Errors of Metabolism: These are rare genetic disorders that affect key metabolic pathways, such as mitochondrial myopathies or glycogen storage diseases, leading to chronic or intermittent lactic acidosis.
The Diagnostic Workup
The diagnosis of lactic acidosis requires a high index of suspicion, as its signs and symptoms are often non-specific and reflective of the underlying critical illness.
Initial Clinical Assessment
- Patient History: A thorough history is critical to identify potential causes. Inquire about diabetes (and metformin use), alcohol use, recent infections, symptoms of heart failure, toxin ingestion, or a history of liver or kidney disease.
- Physical Examination: Look for signs of systemic hypoperfusion: hypotension, tachycardia, altered mental status, cool and clammy skin, and decreased urine output. A key clinical sign is Kussmaul respiration—deep, rapid breathing, which is the body’s compensatory mechanism to blow off excess CO2 and counteract the metabolic acidosis.
Laboratory Evaluation
- Serum Lactate: This is the definitive test. A normal lactate level is typically < 2 mmol/L. Lactic acidosis is generally defined as a serum lactate level > 4-5 mmol/L in the context of acidemia. Serial measurements are crucial to monitor the response to treatment.
- Arterial Blood Gas (ABG): An ABG is essential and typically reveals the classic triad of a high anion gap metabolic acidosis:
- Low pH: < 7.35
- Low Serum Bicarbonate (HCO3-): < 22 mEq/L
- Elevated Anion Gap: The anion gap is calculated as [Na+] – ([Cl-] + [HCO3-]). A value > 12 mEq/L is considered elevated. Lactate is an unmeasured anion that contributes to this gap.
- Comprehensive Metabolic Panel (CMP): This provides vital clues to the underlying etiology. Assess for:
- Renal Failure: Elevated blood urea nitrogen (BUN) and creatinine can suggest a cause (e.g., MALA) or a consequence of shock.
- Liver Dysfunction: Elevated liver enzymes (AST, ALT) and bilirubin may point to liver failure as the reason for impaired lactate clearance.
- Glucose Levels: Hyperglycemia can be seen in sepsis or diabetic ketoacidosis (which can coexist with lactic acidosis).
Identifying the Underlying Cause
Once lactic acidosis is confirmed, the diagnostic focus shifts entirely to identifying and addressing the root cause. This may involve:
- Infection Workup: Blood cultures, urine analysis, and chest X-rays to search for a source of sepsis.
- Cardiovascular Evaluation: An electrocardiogram (ECG), cardiac enzymes (troponin), and an echocardiogram to assess for myocardial infarction or heart failure.
- Imaging: CT scans of the abdomen and pelvis may be necessary to rule out sources of infection (e.g., abscess) or mesenteric ischemia.
- Toxicology Screening: If toxin ingestion is suspected.
The Treatment Strategy
The management of lactic acidosis is a medical emergency that focuses on two primary goals: supporting vital functions and, most importantly, reversing the underlying cause.
Principle 1: Treat the Underlying Cause
This is the cornerstone of therapy. Lactic acidosis will not resolve until the precipitating condition is corrected.
- Sepsis: Administer broad-spectrum antibiotics and initiate source control (e.g., draining an abscess).
- Shock: Restore circulation with intravenous fluids and vasopressors.
- Myocardial Infarction: Pursue emergent reperfusion therapy (e.g., percutaneous coronary intervention).
- Toxin/Drug-Induced: Stop the offending agent immediately. Administer specific antidotes if available.
Principle 2: Restore Tissue Perfusion and Oxygenation
For Type A lactic acidosis, the immediate goal is to improve oxygen delivery to the tissues. This involves standard resuscitation protocols:
- Airway, Breathing, Circulation (ABCs): Ensure a patent airway and adequate oxygenation, potentially requiring mechanical ventilation.
- Intravenous Fluids: Judicious administration of crystalloid fluids (e.g., Lactated Ringer’s or normal saline) is the first step to restore intravascular volume and improve blood pressure.
- Vasopressors: If the patient remains hypotensive despite adequate fluid resuscitation, vasopressors (e.g., norepinephrine) are used to increase mean arterial pressure and maintain organ perfusion.
Adjunctive and Controversial Therapies
- Sodium Bicarbonate: The use of bicarbonate to buffer the blood and raise the pH is highly controversial. While seemingly logical, it has not been shown to improve outcomes and may be harmful. Potential adverse effects include volume overload, hypernatremia, a paradoxical worsening of intracellular acidosis, and shifting the oxyhemoglobin curve to the left, which impairs oxygen release to tissues. Its use is generally discouraged and reserved only for cases of extreme, life-threatening acidemia (e.g., pH < 7.1) where it may be needed to improve cardiovascular responsiveness to catecholamines.
- Renal Replacement Therapy (RRT): Hemodialysis or continuous renal replacement therapy (CRRT) can be a life-saving intervention in specific situations. It is effective at clearing lactate from the blood, correcting severe acidemia, and removing certain toxins like metformin, ethylene glycol, and salicylates.
- Thiamine Supplementation: In patients at risk for thiamine deficiency (e.g., those with alcohol use disorder or malnutrition), empirical administration of intravenous thiamine is a safe and reasonable intervention to support proper pyruvate metabolism.
Conclusion
Lactic acidosis is a grave metabolic derangement that signals severe underlying cellular distress. Its successful management hinges on rapid recognition, a systematic diagnostic workup to identify its root cause, and aggressive, targeted therapy. The primary focus must always be on treating the precipitating condition and restoring adequate tissue oxygenation, as therapies aimed solely at correcting the pH are often ineffective and potentially harmful.
References
- Kraut, J. A., & Madias, N. E. (2014). Lactic acidosis. New England Journal of Medicine, 371(24), 2309-2319.
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., … & Vincent, J. L. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine, 362(9), 779-789.
- Jaber, S., Paugam, C., Futier, E., Lefrant, J. Y., Lasocki, S., Lescot, T., … & Asehnoune, K. (2018). Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. The Lancet, 392(10141), 31-40.
- Andersen, L. W., Mackenhauer, J., Roberts, J. C., Berg, K. M., Cocchi, M. N., & Donnino, M. W. (2013). Etiology and therapeutic approach to elevated lactate. Mayo Clinic Proceedings, 88(10), 1127-1140.
- Suetrong, B., & Walley, K. R. (2016). Lactic acidosis in sepsis: a commentary and review. Journal of Critical Care, 33, 274-279.
